Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2012
11/08/2012WO2012112438A3 Anti-microbial agents and compositions and methods of production and use thereof
11/08/2012WO2012106251A3 Pertussis vaccine
11/08/2012WO2012093859A3 Antifungal composition including polycyclic peptide compound and method for producing same
11/08/2012WO2012092411A3 Phenanthridine macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012092409A3 Macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012062685A3 Pharmaceutical composition for treating hcv infections
11/08/2012WO2011003018A9 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof
11/08/2012US20120283695 Transdermal drug delivery patch and method of controlling drug release of the same by near-ir
11/08/2012US20120283334 Treatment of Viral Infections
11/08/2012US20120283330 Methods for the treatment of dermatological disorders
11/08/2012US20120283318 Replicating viral vectors for gene therapy
11/08/2012US20120283301 S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptase
11/08/2012US20120283297 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
11/08/2012US20120283268 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
11/08/2012US20120283265 Compounds useful for treating aids
11/08/2012US20120283251 Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
11/08/2012US20120283250 Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors
11/08/2012US20120283249 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283240 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283237 Novel cephalosporins useful as antibacterial agents
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283225 Combination Therapy for Skin Disorders
11/08/2012US20120283219 Diaminopteridine derivatives
11/08/2012US20120283210 Maribavir isomers, compositions, methods of making and methods of using
11/08/2012US20120283209 Antibacterial aminoglycoside analogs
11/08/2012US20120283208 Antibacterial aminoglycoside analogs
11/08/2012US20120283207 Antibacterial aminoglycoside analogs
11/08/2012US20120283201 9-substituted minocycline compounds
11/08/2012US20120283195 Glycopeptide phosphonate derivatives
11/08/2012US20120283177 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv)
11/08/2012US20120283176 Short fatty acid tail polymyxin derivatives and uses thereof
11/08/2012US20120283175 Antibacterial compositions
11/08/2012US20120283174 Antibiofilm glycopeptides
11/08/2012US20120283173 Novel compositions for treating pseudomonas infection
11/08/2012US20120283172 Modified porcine somatotropin polypeptides and their uses
11/08/2012US20120283171 Modified bovine somatotropin polypeptides and their uses
11/08/2012US20120282673 Functional mutation in respiratory syncytial virus
11/08/2012US20120282354 Composition for preventing or treating diseases caused by influenza viruses
11/08/2012US20120282353 Methods, compositions and articles of manufacture for hif modulating compounds
11/08/2012US20120282351 System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino Acids
11/08/2012US20120282350 Performance enhancing compositions and methods of use
11/08/2012US20120282348 Antimicrobial Silver Hydrogel Composition For The Treatment of Burns And Wounds
11/08/2012US20120282328 Dual action, inhaled formulations providing both an immediate and sustained release profile
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282294 Refrigerator-temperature stable influenza vaccine compositions
11/08/2012US20120282293 Multivalent Live Vector Vaccine against Clostridium difficile-Associated Disease
11/08/2012US20120282292 Methods and compositions related to immunogenic fibrils
11/08/2012US20120282291 Vaccine vectors and methods of enhancing immune responses
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282289 Staphylococcal antigens
11/08/2012US20120282288 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides
11/08/2012US20120282287 Novel Flavivirus Antigens
11/08/2012US20120282283 Production of closed linear dna
11/08/2012US20120282281 Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR)
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282273 Recombinant antibodies against h1n1 influenza
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders
11/08/2012US20120282268 Novel Cell Wall Components of Enterococci and Uses Thereof
11/08/2012US20120282264 Neutralizing antibodies to hiv-1 and their use
11/08/2012US20120282260 Anti-herpes simplex virus antibodies and methods of use thereof
11/08/2012US20120282247 Methods and compositions involving protective staphylococcal antigens, such as ebh polypeptides
11/08/2012US20120282246 Compositions and methods for antibody and ligand identification
11/08/2012US20120282224 Markers associated with ribavirin-induced anemia
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282221 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120282213 Use of Polymeric or Oligomeric Active Ingredients for Medical Articles
11/08/2012US20120282202 Aqueous composition for topical application, method of preparation, uses and device
11/08/2012US20120282198 Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
11/08/2012US20120282192 Oral care compositions
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2839790A1 Rapid dissolve tablet compositions for vaginal administration
11/08/2012CA2836768A1 Amorphous solid salts
11/08/2012CA2834999A1 Novel cephalosporins useful as antibacterial agents
11/08/2012CA2834128A1 Peptide oligonucleotide conjugates
11/08/2012CA2833780A1 Prenylated hydroxystilbenes
11/07/2012EP2520293A1 Compounds for use in the treatment of filariasis
11/07/2012EP2519539A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/07/2012EP2519538A1 Cyclosporine analogues
11/07/2012EP2519506A1 Hepatitis c virus inhibitors
11/07/2012EP2519505A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
11/07/2012EP2519504A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
11/07/2012EP2519503A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
11/07/2012EP2519263A1 Lipopeptide- and lipoprotein-conjugates and its use
11/07/2012EP2519252A1 Pythium immunotherapy
11/07/2012EP2519250A1 Interferon analogs
11/07/2012EP2519243A2 Compositions and methods for treating hepatitis b virus infection
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012CN1985827B Compound ciprofloxacin injection for animal and its preparing process
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN102770452A An IgY for a PA-MSHA bacterial strain, and preparation method and application thereof
11/07/2012CN102770413A 5-amino- 4-hydroxypentoyl amides
11/07/2012CN102770181A Novel antiviral compounds
11/07/2012CN102770141A Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1798